Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Curtis Rosebraugh"'
Autor:
Amy Egan, Kristina Dunder, Curtis Rosebraugh, B. Timothy Hummer, Pieter A. de Graeff, Todd Bourcier, Eberhard Blind
Publikováno v:
New England Journal of Medicine, 370(9), 794-797. MASSACHUSETTS MEDICAL SOC
After evaluating a safety signal regarding pancreatitis and pancreatic cancer in patients using incretin-based drugs, the Food and Drug Administration and the European Medicines Agency conclude that assertions of a causal association are inconsistent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d491777c6d79bab7dcb5e15a873697e
https://doi.org/10.1056/nejmp1314078
https://doi.org/10.1056/nejmp1314078
Autor:
Yi Tsong, Min Chen, Feng Zhou, David A. Flockhart, Denise Toyer, Curtis Rosebraugh, Charlene M. Flowers, Ann Corken Mackey, Peter K. Honig
Publikováno v:
Pharmacoepidemiology and Drug Safety. 12:97-101
Purpose Evaluate whether a 15-minute lecture intervention will improve adverse drug reaction reporting quality on standard MedWatch forms. Methods Seventy-eight 4th-year medical students were randomized to intervention ‘Group-A’ or non-interventi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e62ec8311063a0158a47235221527c1
https://doi.org/10.1002/pds.797
https://doi.org/10.1002/pds.797
Autor:
Curtis Rosebraugh, Mary H. Parks
Publikováno v:
The New England journal of medicine. 362(9)
On January 25, the FDA approved liraglutide, a glucagon-like-peptide-1 receptor agonist that can improve glycemic control in adults with type 2 diabetes. Drs. Mary Parks and Curtis Rosebraugh discuss the benefits and potentially serious safety concer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6aa224e3921beea8338a11ea23793efd
https://pubmed.ncbi.nlm.nih.gov/20164475
https://pubmed.ncbi.nlm.nih.gov/20164475
Publikováno v:
New England Journal of Medicine. 367:1577-1579
After weighing the risks and benefits, the FDA recently approved two new drugs as adjuncts to a reduced-calorie diet and increased physical activity for chronic weight management in obese or overweight adults with at least one weight-related coexisti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4f92a408ba422756ec0d270b66f8c08
https://doi.org/10.1056/nejmp1211277
https://doi.org/10.1056/nejmp1211277
Publikováno v:
Clinical Pharmacology & Therapeutics. 71:4-10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ecf62d0af20ce34bc7de2af808219f2c
https://doi.org/10.1067/mcp.2002.120676
https://doi.org/10.1067/mcp.2002.120676
Publikováno v:
Fair Disclosure Wire (Quarterly Earnings Reports). 08/24/2023.
Autor:
Richters, Scout
Publikováno v:
Journal of Law & Policy. 2013, Vol. 22 Issue 1, p393-432. 40p.
Autor:
Matlock, Aaron1 (AUTHOR), Allan, Nicholas1 (AUTHOR), Wills, Brandon2 (AUTHOR), Kang, Christopher1 (AUTHOR), Leikin, Jerrold B.3 (AUTHOR) jleikin@northshore.org
Publikováno v:
Clinical Toxicology (15563650). Jul2011, Vol. 49 Issue 6, p443-447. 5p.
Autor:
Termini, Roseann B.1 rbtermini@mail.widener.edu, Lee, Miranda2 mofoto22@gmail.com
Publikováno v:
Oklahoma City University Law Review. Summer2011, Vol. 36 Issue 2, p351-373. 23p.
Publikováno v:
Applied Clinical Trials. Dec2008, Vol. 17 Issue 12, p64-67. 4p.